Cobo Marc — SEC insider filings

SEC reporting owner CIK 1816654. 6 insider filings on record with FilingPulse; latest filed 2026-11-17.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2020-09-14 to 2026-11-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
BridgeBio Oncology Therapeutics, Inc. (BBOT)Principal Accounting Officer5—1 leg · 78 sh · $1856
Tricida, Inc. (TCDA)SVP, Finance & CAO1——1

Insider filings — Cobo Marc

FiledFormIssuerReported transactionsSource
2026-11-174BridgeBio Oncology Therapeutics, Inc. (BBOT)Sale (S): 78 @ $2.37EDGAR
2026-10-234BridgeBio Oncology Therapeutics, Inc. (BBOT)Tax withholding (F): 203 @ $2.68EDGAR
2026-10-054BridgeBio Oncology Therapeutics, Inc. (BBOT)Tax withholding (F): 126 @ $3.94EDGAR
2026-09-144BridgeBio Oncology Therapeutics, Inc. (BBOT)Grant/award (A): 9,038 @ $0 · Tax withholding (F): 203 @ $5.52 · Grant/award (A): 43,700 (derivative) @ $0EDGAR
2026-07-064BridgeBio Oncology Therapeutics, Inc. (BBOT)Tax withholding (F): 125 @ $7.80EDGAR
2020-09-144Tricida, Inc. (TCDA)Grant/award (A): 3,000 @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-04 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1816654 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs